Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

435
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
435
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

7.8K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
7.8K
Difference from Background: Limit of Detection01:05

Difference from Background: Limit of Detection

8.5K
The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Trends in Medicaid Hearing Aid Coverage for Adults in the United States: 2003-2023.

American journal of audiology·2026
Same author

Patient-Centered Hearing Intervention Leads to Positive Outcomes: The Association of Hearing Technology With Daily Hearing Aid Usage and Listening Goals in the Aging and Cognitive Health Evaluation in Elders Study.

American journal of audiology·2026
Same author

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.

EClinicalMedicine·2026
Same author

Familism, Family Cohesion, and Hearing Loss in U.S. Hispanic/Latino Adults.

Ear and hearing·2026
Same author

Why Hearing Health Must Be Part of Voice Biomarker Research.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Community-Informed Adaptation of a School-Based Hearing Health Intervention: Formative Evaluation for an Effectiveness-Implementation Trial.

Ear and hearing·2026
Same journal

Hearing Difficulty, Health Literacy, and Poorer Health Among Adults in the United States: 2016 Behavioral Risk Factor Surveillance Study.

Ear and hearing·2026
Same journal

Cultural Differences in Listening Environments Between Hispanic and White Non-Hispanic Cochlear Implant Users.

Ear and hearing·2026
Same journal

Detection of Inner Ear Malformations Based on Simple Anatomical Measurements: A Model Approach.

Ear and hearing·2026
Same journal

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

Ear and hearing·2026
Same journal

Quantifying Miscommunications in Triadic Conversations: Effects of Hearing Impairment, Hearing Aids, and Background Noise.

Ear and hearing·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Guest Editorial: Background and Rationale for Clinical Trial Registration

Harvey B Abrams1, Theresa H Chisolm, Victoria A Sanchez

  • 1Auditory Rehabilitation and Clinical Trials Laboratory, Department of Communication Sciences and Disorders, University of South Florida, Tampa, Florida, USA, Department of Audiology Research, Starkey Hearing Technologies, Eden Prairie, Minnesota, USA Auditory Rehabilitation and Clinical Trials Laboratory, Department of Communication Sciences and Disorders, University of South Florida, Tampa, Florida, USA Starkey Hearing Technologies, Eden Prairie, Minnesota, USA.

Ear and Hearing
|January 26, 2018
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
10:25

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping

Published on: September 25, 2019

49.5K

Related Experiment Videos

Last Updated: Feb 15, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
10:25

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping

Published on: September 25, 2019

49.5K